PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) Q1 2025 Earnings

PMCB·Reported March 17, 2025·Before market open

Diluted EPS came in at $-0.10.

Diluted EPS
$-0.10
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001683168-25-001669

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about PharmaCyte Biotech, Inc.'s Q1 2025 earnings report.

PharmaCyte Biotech, Inc. (PMCB) reported Q1 2025 earnings on March 17, 2025 before market open.

PharmaCyte Biotech, Inc. reported diluted EPS of $-0.10 for Q1 2025.

You can read the 10-Q periodic report (0001683168-25-001669) directly on SEC EDGAR. The filing index links above go to sec.gov.